References
- Rubin B., Antonaccio MJ. Captopril. In: Scriabine A. ed. Pharmacology of antihypertensive drugs. New York, Raven Press 21–42, 1980
- Patchett A. The design of enalapril. In: Doyle A.E., Bearn AG, eds. Hypertension and the angiotensin system: Therapeutic approaches. New York, Raven Press 155–165, 1984
- Duchin K.L., Singhvi S.M., Willard D.A., Migdal of B.H., McKinstry DN. Captopril kinetics. Clin. Pharmacol. Ther. 31: 452–58, 1982
- Matsuki Y., Ito T., Fukuhara K., Nakamura T., Kimura M., Ono H. Determination of captopril and its disulphide in biological fluids. J. Chromatography 239: 585–94, 1982
- Koike H., Ikeda T., Komai T., Kawai K., Miyamoto M., Shindo H. Relationship between inhibition of pressor response to angiotensin I and blood concentration of captopril following a single oral administration to dogs. Eur. J. Pharmacol. 69: 447:51, 1981
- Cody R.J., Schaer G.L., Covit A.B., Pondolfino K., Williams G. Captopril kinetics in chronic congestive heart failure. Clin. Pharmacol. 32: 721–26, 1982
- Onoyama K., Hirakata H., Iseki K., Fujimi S., Omae T., Kobayashi M., Kawahara Y. Blood concentration and urinary excretion of captopril (SO 14,225) in patients with chronical renal failure. Hypertension 3: 456–459, 1981
- Duncan E.M., Martin V.I.., Williams B.C., Al-Dujaili E.A.S., Edwards R.W. Development and optimisation of a radioimmunoassay for plasma captopril. Clin. Chem. Acta 295–303, 1983
- Fyhrquist E., Tikkanen L., Grönhagen-Riska C., Hortling L., Hichens M. Inhibitor binding assay for Angiotension-Converting Enzyme. Clin. Chem. 30, 696–700 1984
- Swanson B.N., Hichens M., Mojaverian P. Angiotensin converting enzyme activity in human serum: Relationship to enzyme inhibitor in vivo and in vitro. Res. Commun. Chem. Pathol. Pharmacol. 33: 525–36, 1981
- Biollaz J., Schelling J.L., Jacot des Combes B., Brunner D.B., Desponds G., Brunner H.R. Enalapril maleate and a lysine analogue (MK–521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Brit. J. Pharmacol. 14:363–68, 1982
- Funae Y., Komori T., Sasaki D., Yamamoto K. Inhibitor of angiotensin converting enzyme: (4R)-3-(2S)-3-mercapto-2-methylpropanoyl-4-thiazolidinecarboxylic acid (YS 980). Biochem. Pharmacol. 29: 1543–47, 1980
- Boomsma F., de Bruyn J.H.B., Derkx F.H.M., Schalekamp M.A.D. Opposite effects of captopril on angiotensin converting enzyme "activity" and "concentration"; relation between enzyme inhibition and long-term blood pressure responses. Clin. Science 60: 491–98, 1981
- Fyhrquist F., Grönhagen-Riska C., Hortling L., Forslund T., Tikkanen L., Klockars M. The induction of angiotensin converting enzyme by its inhibitors. Clin. Exp. Hypertension A5 (7&8): 1319–1330, 1983
- Fyhrquist F., Grönhagen-Riska C., Hortling L., Forslund T., Tikkanen I. Regulation of angiotensin converting enzyme. J. Hypertension 1 (Suppl 1): 25–30, 1983